A Study of Ziftomenib, an Oral Menin Inhibitor, in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

RECRUITING

Memorial Sloan-Kettering Cancer Center, New York

RECRUITING

Temple University Health System, Philadelphia

RECRUITING

Duke University Medical Center, Durham

RECRUITING

Mayo Clinic Cancer Center, Jacksonville

RECRUITING

University of Miami, Miami

RECRUITING

Sarah Cannon Research Institute, Nashville

RECRUITING

Ohio State University, Columbus

RECRUITING

University of Michigan, Ann Arbor

RECRUITING

University of Iowa, Iowa City

RECRUITING

Mayo Clinic Cancer Center, Rochester

RECRUITING

Northwestern University, Chicago

RECRUITING

Sarah Cannon Research Institute, Dallas

RECRUITING

University of Texas, Houston

RECRUITING

University of Texas Health Science Center, San Antonio

RECRUITING

Sarah Cannon Research Institute, Denver

RECRUITING

University of Utah, Salt Lake City

RECRUITING

Mayo Clinic Cancer Center, Phoenix

RECRUITING

University of Southern California, Los Angeles

RECRUITING

UCLA Santa Monica Medical Center, Santa Monica

RECRUITING

University of California, San Diego, La Jolla

RECRUITING

Oregon Health & Science University, Portland

RECRUITING

Yale University School of Medicine, New Haven

RECRUITING

Harvard University, Boston